Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 52 device-driven procedures, CMS 2024
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 73 | 4,473−1.9%/yr | −1.9%/yr | 6.41.0× | 70% | 4,560 in 2030+0.3%/yr |
| Tumor & fibroid embolization |
How the numbers are made · Every state · Compare two markets
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
| 11 |
| 723+24%/yr |
| +24%/yr |
| 1.01.9× |
| 78% |
| 1,640 in 2030+15%/yr |
| Tumor ablation | 3 | 264+12%/yr | +12%/yr | 0.41.4× | 0% | 460 in 2030+9.6%/yr |
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.